TrialPediatric nephrology (Berlin, Germany)2017

Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.

Nicholas J A Webb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.